Radiofrequency ablation was statistically on par with surgery when it came to survival after an early recurrence of liver cancer, but surgery provided more benefit if the disease was a bit more ...

Early hepatic recurrence of colorectal cancer indicates aggressive disease and an unfavorable prognosis. Although the results of this study seem to indicate that survival after RFA is equivalent to ...

The National Institute for Clinical Excellence is examining radiofrequency ablation of liver tumours and will publish guidance on its safety and efficacy for the NHS in England and Wales. The ...

SBRT showed improved LPFS over RFA in treating single recurrent small HCC, especially for tumors ≤2 cm. Both SBRT and RFA demonstrated similar PFS, OS, and safety profiles, with mild to moderate side ...

A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. Background: Hepatic resection is the mainstay of management for colorectal liver ...

The cancer vaccine therapy using DCs derived from iPS cells (iPSDCs) expressing TAA gene. A single institute retrospective trial of concurrent chemotherapy with SIR-Sphere versus SIR-Sphere alone in ...

Percutaneous imaging guided radiofrequency ablation (RFA) of hepatocellular carcinoma is a safe and effective technique, with benefits such as reduced post-procedural pain and length of hospital stay, ...

Surgery and radiofrequency ablation showed similar 5-year survival rates for small liver tumors. Both treatments had nearly identical 5-year recurrence-free survival outcomes. Patient and tumor ...

This study calculated survival rates for 2 treatment approaches to patients with early stage recurrent hepatocellular carcinoma (HCC). At 5 years, patients who underwent a repeat hepatectomy versus ...

Colorectal cancer is the second most common cancer in women and the third most common cancer in men in the UK. The liver is the most common site for metastases. Curative treatment for patients with ...